Ramadevi Subramani Reddy | Cancer Biology | Research Excellence Award

Dr. Ramadevi Subramani Reddy | Cancer Biology | Research Excellence Award

Associate Professor | Texas Tech University Health Sciences Center El Paso | United States

Dr. Ramadevi Subramani Reddy is an Associate Professor at Texas Tech University Health Sciences Center El Paso and a researcher in Cancer Biology with extensive expertise in molecular and translational oncology. She holds advanced training in biochemistry and cancer biology, with doctoral specialization in cancer-related cellular mechanisms, including differentiation, cell cycle regulation, and apoptosis. Her professional experience spans progressive research roles from competitive fellowships to senior research and faculty positions, demonstrating sustained leadership in funded cancer research programs. Her work focuses on molecular signaling pathways, inflammation-mediated cancer progression, and translational strategies for cancer prevention and therapy, resulting in a strong body of peer-reviewed publications with significant citation impact. Dr Reddy has contributed to multidisciplinary research initiatives, mentored trainees, and supported collaborative cancer research efforts. Her career is distinguished by nationally and internationally funded fellowships and research awards that recognize her scientific rigor, consistency, and impact in advancing cancer biology research.

Citation Metrics (Google Scholar)

1732
1200
600
300
0

1732

34

24

Citations

Documents

h-index

Milad Shirvaliloo | Cancer Epigenetics | Best Researcher Award 

Dr. Milad Shirvaliloo | Cancer Epigenetics | Best Researcher Award 

Research Associate | Iran University of Medical Sciences | Iran

Dr. Milad Shirvaliloo is an accomplished physician–researcher specializing in epigenetics with a focus on cancer and pulmonary medicine. Holding a Doctor of Medicine and a Master of Business Administration in Health Sciences, he combines clinical expertise with research innovation to advance precision medicine. As a Postgraduate Researcher at the Finetech in Medicine Research Center, he leads studies on nanoparticle-based therapeutic interventions and their effects on histone acetylation in cancer. Dr. Shirvaliloo has authored more than forty peer-reviewed publications and a book chapter, contributing extensively to understanding molecular and epigenetic mechanisms in disease pathogenesis. His scholarly output includes first-author and single-author papers in leading journals, where he explores the roles of histone modifications, long noncoding RNAs, and nanobiosensor technologies in diagnostics and therapeutics. He has demonstrated academic leadership as an Editorial Board Member for Epigenomics and Molecular and Cellular Biochemistry and has served as a peer reviewer for over sixty high-impact journals. Recognized for his scientific excellence and editorial contributions, he has received the Best Researcher Award for his outstanding achievements in biomedical science. His ongoing work reflects a strong commitment to translational research, interdisciplinary collaboration, and mentorship of emerging scientists. With a clear vision for integrating molecular biology, nanotechnology, and clinical application, Dr. Shirvaliloo exemplifies the future of innovative medical research and continues to make significant contributions to global health advancement.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Heris, R. M., Shirvaliloo, M., Abbaspour-Aghdam, S., Hazrati, A., Shariati, A., & others. (2022). The potential use of mesenchymal stem cells and their exosomes in Parkinson’s disease treatment. Stem Cell Research & Therapy, 13(1), 371.

2. Sheervalilou, R., Shirvaliloo, M., Dadashzadeh, N., Shirvalilou, S., Shahraki, O., & others. (2020). COVID‐19 under spotlight: A close look at the origin, transmission, diagnosis, and treatment of the 2019‐nCoV disease. Journal of Cellular Physiology, 235(12), 8873–8924.

3. Aghbash, P. S., Eslami, N., Shirvaliloo, M., & Baghi, H. B. (2021). Viral coinfections in COVID‐19. Journal of Medical Virology, 93(9), 5310–5322.

4. Shirvalilou, S., Khoei, S., Esfahani, A. J., Kamali, M., Shirvaliloo, M., & others. (2021). Magnetic hyperthermia as an adjuvant cancer therapy in combination with radiotherapy versus radiotherapy alone for recurrent/progressive glioblastoma: A systematic review. Journal of Neuro-Oncology, 152(3), 419–428.

5. Razlansari, M., Jafarinejad, S., Rahdar, A., Shirvaliloo, M., Arshad, R., & others. (2023). Development and classification of RNA aptamers for therapeutic purposes: An updated review with emphasis on cancer. Molecular and Cellular Biochemistry, 478(7), 1573–1598.*

Dr. Milad Shirvaliloo’s pioneering research in epigenetics and nanomedicine bridges molecular science with clinical application, driving innovations in cancer and pulmonary disease diagnostics and therapies. His work advances precision medicine and fosters global scientific collaboration, contributing to more effective, personalized healthcare solutions.

Sukanta Nath | Cancer Research | Outstanding Scientist Award

Dr. Sukanta Nath | Cancer Research | Outstanding Scientist Award 

Research Scientist at Atal Bihari Vajpayee Regional Cancer Centre ,India

Dr. Sukanta Nath is a distinguished Research Scientist with over 13 years of experience in biotechnology and cancer research. He holds a Ph.D. in Biotechnology from Gauhati University and currently serves at the Atal Bihari Vajpayee Regional Cancer Centre, Tripura. His career spans prestigious institutions including the Indian Institute of Science, Aurigene Discovery Technologies, and Agility Diagnostics. Dr. Nath has contributed significantly to the fields of molecular biology, virology, and oncology through numerous research projects, publications, and conference presentations. He has a strong background in molecular profiling, gene expression, and cancer diagnostics, particularly Acute Myeloid Leukaemia. His dedication to advancing healthcare is also evident through his contributions to nursing intervention research in oral cancer patients. Recognized with multiple awards for research excellence and presentation, Dr. Nath continues to serve as a mentor, reviewer, and active participant in scientific forums. His work reflects a blend of academic rigor and translational medical relevance.

🔹 Professional Profile

🏆Strengths for the Award

  1. Extensive Research Experience:
    Dr. Sukanta Nath possesses more than 13 years of experience in cancer research, molecular biology, and biotechnology. His academic and professional journey through reputed institutions like IISc Bangalore, Aurigene Discovery Technologies, and Agility Diagnostics highlights a consistent dedication to scientific advancement.

  2. Specialization in Molecular Oncology:
    His Ph.D. research focused on molecular profiling in Acute Myeloid Leukemia (AML), specifically targeting key mutations such as FLT3, NPM1, and PML-RARα. This demonstrates a deep understanding of molecular cancer diagnostics.

  3. Translational and Clinical Research:
    Dr. Nath has successfully translated laboratory research into clinical practice, particularly in studies involving oral cancer patient recovery, anxiety, and fatigue. His interdisciplinary focus bridges molecular mechanisms with patient-centered care.

  4. Recognized Contributions and Awards:
    He has received notable recognitions, including the Best Researcher Award from ScienceFather and awards for oral and poster presentations at national academic events. He was also awarded the DBT-BCIL Fellowship, demonstrating government-level acknowledgment of his potential.

  5. Relevant and Recent Publications:
    His 2025 publication on high-risk HPV genotypes among women in North–East India contributes to both regional public health and global understanding of cervical cancer prevention, reflecting timely and impactful research.

  6. Mentorship and Scientific Involvement:
    Dr. Nath actively serves as a peer reviewer and mentor, supporting the broader scientific community and demonstrating a commitment to research ethics and academic development.

🎓 Education

Dr. Sukanta Nath pursued his Ph.D. in Biotechnology from Gauhati University, where he conducted impactful research on molecular profiling in Acute Myeloid Leukaemia. Prior to that, he completed his Master of Science in Biotechnology from Utkal University, where he gained foundational expertise in molecular biology and immunological techniques. His undergraduate studies were in the biological sciences, with a B.Sc. in Botany, Zoology, and Physiology from the University of Calcutta. He received his higher secondary and school education under the Tripura Board of Secondary Education. Throughout his academic journey, Dr. Nath has consistently focused on life sciences, biotechnology, and biomedical research, building a robust academic foundation that supports his ongoing professional contributions. His education was complemented by several technical training programs and hands-on experiences that prepared him for roles in molecular diagnostics, cancer biology, and clinical research.

💼 Experience

Dr. Sukanta Nath has a rich professional background with over 13 years in research and diagnostics. He is currently a Research Scientist at the Atal Bihari Vajpayee Regional Cancer Centre in Tripura, focusing on oncology and postoperative care studies. Previously, he worked as a Research Associate at the College of Fisheries, Central Agricultural University, Tripura. His industry experience includes a key role as Molecular Scientist and Quality Manager at Agility Diagnostics, Delhi. At Gauhati University, he served both as a Ph.D. scholar and Junior Research Fellow, contributing to leukemia-focused molecular studies. Dr. Nath also held a Research Associate role at Aurigene Discovery Technologies (Dr. Reddy’s Lab) and served as a Project Assistant at IISc Bangalore in a CSIR-funded cancer genomics project. His career reflects a synergy between academic research and clinical application, marked by multidisciplinary collaborations, laboratory expertise, and contributions to cancer diagnostics, infectious disease monitoring, and healthcare quality assurance.

🏆 Awards and Honors

Dr. Sukanta Nath has been honored with several prestigious awards recognizing his excellence in research and presentation. He received the Best Researcher Award from ScienceFather during the 23rd International Research Data Analysis Excellence Awards. His scientific presentations have also been lauded: he secured First Place for Best Oral Presentation at the 1st NE Hematology Tutorial (2016) and Third Place for Best Poster at the National Seminar on Climate-Smart Aquaculture and Fisheries (2019). Dr. Nath was also selected for a Biotech Consortium India Limited (BCIL) Fellowship under the DBT, Government of India. He has been acknowledged for his performance by Aurigene Discovery Technologies and has received a Certificate of Appreciation for his contributions. Furthermore, he served as a peer reviewer for journals such as Patient Preference and Adherence. His commitment to research, education, and scientific excellence is evident through these national and international recognitions.

🔬 Research Focus on Cancer Research

Dr. Sukanta Nath’s research centers on molecular biology, cancer genomics, and clinical oncology, with special emphasis on Acute Myeloid Leukaemia (AML). His Ph.D. and subsequent work have involved extensive molecular profiling of genetic mutations such as NPM1, FLT3, AML1/ETO, and PML/RARα, which are crucial in leukemia diagnostics and prognosis. At the Regional Cancer Centre in Tripura, he has pioneered studies addressing post-surgical recovery, anxiety, and fatigue in oral cancer patients, highlighting his translational focus on improving patient outcomes. His interests extend into virology, where he has worked on hepatitis genotyping and viral diagnostics. Dr. Nath also contributes to public health through studies on COVID-19 prevalence and KAP (knowledge, attitude, practice) among cancer patients. His multidisciplinary approach bridges bench-side molecular research with bedside clinical care, making his work relevant for both academic advancements and real-world medical applications. His contributions are marked by high-impact publications and collaborative studies.

📚 Publications Top Notes

Title:Molecular epidemiology and genotype distribution of genital high-risk human papillomavirus among women in North–East India

Journal:Egyptian Journal of Medical Human Genetics

Year:2025

Summary:
This study focuses on the molecular epidemiology of high-risk genital human papillomavirus (HPV) among women in North–East India. It aims to identify the prevalent HPV genotypes in the region and understand their distribution patterns. Using molecular diagnostic methods, the research highlights the frequency of various high-risk HPV strains, contributing to better-informed screening and prevention strategies, including HPV vaccination programs in the area. The study plays a significant role in regional public health planning for cervical cancer prevention.

📌 Conclusion

Dr. Sukanta Nath exemplifies a dedicated and versatile researcher whose work spans both the molecular and clinical domains of biomedical science. His 13+ years of experience reflect a blend of academic precision, research innovation, and patient-centered study design. With a Ph.D. focused on genetic profiling in leukemia and extensive research into oral cancer care, Dr. Nath has significantly contributed to the understanding and treatment of critical health conditions. His collaborations with reputed institutions and involvement in both diagnostics and therapeutic research underscore his comprehensive expertise. Beyond technical acumen, his mentorship, peer review contributions, and public health studies show a commitment to improving healthcare at multiple levels. Recognized through awards and fellowships, his contributions continue to impact oncology, virology, and molecular diagnostics. As he progresses in his career, Dr. Nath stands as a role model for translational researchers aiming to bridge the gap between laboratory science and clinical excellence.

Olga Moskalenko | Medicine | Best Researcher Award

Assoc Prof Dr. Olga Moskalenko | Medicine | Best Researcher Award

Candidate of Biological Sciences, Russia

Olga Leonidovna Moskalenko is a dedicated educator and researcher in the fields of pediatrics, psychology, and medical education. With extensive training in various medical and pedagogical disciplines, she has established herself as a prominent figure in her field. 🌟

Publication Profile

Scopus

Education

Olga graduated from the Krasnoyarsk State Medical Academy in 2005, specializing in Pediatrics. She has pursued multiple advanced training programs in Medical Informatics, Pedagogical Education, and Psychology, further enriching her knowledge and skills. 🎓

Experience

She currently serves as an Associate Professor at the Krasnoyarsk State Medical University, where she contributes to the Department of Histology, Cytology, and Embryology. Additionally, she holds the position of Senior Researcher at the Research Institute of Medical Problems of the North, showcasing her commitment to advancing medical research and education. 🏥

Research Interests

Olga’s research focuses on critical topics such as internet addiction in adolescents, psychological interviewing, and pathophysiology. Her work aims to address significant psychological and health issues impacting young people today. 🔬

Awards

Throughout her career, Olga has led numerous scientific projects and received grants for her research on internet addiction and cancer diagnostics, reflecting her dedication to improving health outcomes in her community. 🏆

Publications

Griffiths, M. D., & Moskalenko, O. L. (2024). Title of the Publication. Journal Name.

Moskalenko, O. L. (2021). Title of the Publication. Journal Name.

Moskalenko, O. L. (2020). Title of the Publication. Journal Name.

 

Rosa María Martínez-Espinosa | Biochemistry | Best Researcher Award

Prof Dr. Rosa María Martínez-Espinosa | Biochemistry | Best Researcher Award

Prof, University of Alicante, Spain

Dr. Rosa María Martínez-Espinosa, born in Alicante, Spain, is a distinguished biochemist and full professor at the University of Alicante. She leads the Applied Biochemistry Research Group and is well-known for her extensive research on extremophiles and their industrial applications. Dr. Martínez-Espinosa has made significant contributions to biotechnology, with over 100 publications in indexed journals, more than 200 conference presentations, and 70 book chapters. She also serves as the Vice President for International Relations and Development Cooperation at the University of Alicante. 🌍🔬

Publication Profile

ORCID

Education

Dr. Martínez-Espinosa earned her PhD in Biology from the University of Alicante in 2003, where she was awarded the Extraordinary Doctorate Award. She previously completed her BSc (Hons) in Biology at the same institution in 1998. 🎓📚

Experience

Dr. Martínez-Espinosa has held various academic positions at the University of Alicante since 2001. She began as an associate professor, advancing to senior lecturer and eventually full professor in 2020. Alongside her teaching, she has served in multiple leadership roles, including Vice-Dean for Postgraduate Programs and Vice-President for International Relations. She has also conducted research at the University of East Anglia, UK, during multiple research visits. 💼🏫

Research Focus

Her research focuses on the metabolism of extremophiles, biotechnological applications of microorganisms, enzyme purification, genetic manipulation of microorganisms, carotenoid production, and environmental bioremediation. Her work is funded by European and national grants, contributing to advances in microbial biotechnology and bioengineering. 🔬🧪

Awards and Honours

Dr. Martínez-Espinosa has been recognized with numerous accolades, including the 2024 Sprint-Valoriza Award for her project on Microbial Biotechnology, multiple Top Reviewer Awards by Web of Science in Biochemistry, Genetics, and Molecular Biology, and the 2013 Excellence in Teaching Award from the University of Alicante. 🏆🎖️

Publication Top Notes

Halocins and C<sub>50</sub> Carotenoids from Haloarchaea: Potential Natural Tools against Cancer

Production of Poly(3-hydroxybutyrate-<i>co</i>-3-hydroxyvalerate) (PHBV) by <i>Haloferax mediterranei</i> Using Candy Industry Waste as Raw Materials

Controversy over the Use of “Shade Covers” to Avoid Water Evaporation in Water Reservoirs